torisel in rcc. , page-7

Hi all. Good digging skint. What encouraged me about the case of the latest patient being treated in the US is the approach of Robert Nagourney, the doctor involved. He appears to have a very focused approach to cancer generally, and a much higher success rate than many others. His approach seems to revolve around carefully testing the sensitivity to the available treatments of the cancer he is treating. This must mean that he found the cells of the latest US patient were sensitive to Coramsine, before the trial was even started. On that basis, it seems to me that "no news" may be "good news". The trial would not have continued if it was having a bad effect on the patient, and it probably would not have continued if it wasn't doing any good. Whatever the situation, we should be getting news on something soon.

Barley